EUVIMEDEUVIMED entdecken
Crossref

Follistatin‐like 1 protects against doxorubicin‐induced cardiotoxicity by preventing mitochondrial dysfunction through the SIRT6/Nrf2 signaling pathway

Haijun Xu, Hong Guo, Zhigang Tang, Ruijun Hao, Shaowei Wang, Ping Jin

Cell Biology International · 2024-06 · 48 (6) · 795-807

DOI: 10.1002/cbin.12147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biology International, online erschienen am 04.03.2024. Verfasst von Haijun Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Yangling Demonstration Zone Hospital, Xi'an, China. Hauptthemen laut MEDLINE: Cardiotoxicity, Follistatin-Related Proteins, Mitochondria, NF-E2-Related Factor 2. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial dysfunction and myocardial remodeling have been reported to be the main underlying molecular mechanisms of doxorubicin‐induced cardiotoxicity. SIRT6 is a nicotinamide adenine dinucleotide‐dependent enzyme that plays a vital role in cardiac protection against various stresses. Moreover, previous studies have demonstrated that FSTL1 could alleviate doxorubicin‐induced cardiotoxicity by inhibiting autophagy. The present study investigated the probable mechanisms of FSTL1 on doxorubicin‐induced cardiotoxicity in vivo and in vitro. We confirmed that FSTL1 exerted a pivotal protective role on cardiac tissue in vivo and on doxorubicin‐induced cell injury in vitro. Furthermore, FSTL1 can alleviate doxorubicin‐induced mitochondrial dysfunction by inhibiting autophagy and apoptosis. Further studies demonstrated that FSTL1 can activate SIRT6 signaling by restoring the SIRT6 protein expression in doxorubicin‐induced myocardial injury. SIRT6 activation elevated the protein expression of Nrf2 in doxorubicin‐induced H9C2 injury. Treatment with the Nrf2 inhibitor ML385 partially antagonized the cardioprotective role of SIRT6 on doxorubicin‐induced autophagy or apoptosis. These results suggested that the protective mechanism of FSTL1 on doxorubicin‐induced cardiotoxicity may be related with the inhibition of autophagy and apoptosis, partly through the activation of SIRT6/Nrf2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiotoxicityFollistatin-Related ProteinsMitochondriaNF-E2-Related Factor 2SirtuinsAnimalsMiceRatsApoptosisAutophagyCell LineDoxorubicinMice, Inbred C57BLMyocytes, CardiacSignal Transduction

Stichwörter der Autor:innen

FSTL1SIRT6apoptosisautophagycardiac remodelingdoxorubicin

Substanzen

DoxorubicinFollistatin-Related ProteinsNF-E2-Related Factor 2Sirtuinssirtuin 6, ratSirt6 protein, mouseFstl1 protein, ratFstl1 protein, mouse

Autor:innen und Institutionen

  • Department of Pediatrics, Yangling Demonstration Zone Hospital, Xi'an, China.
  • Department of Cardiovascular Surgery, Xijing Hospital, Air Force Medical University, Xi'an, China.
  • Department of Cardiovascular Surgery, Shang Luo Central Hospital, Shang Luo, China.
  • Department of Cardiovascular Surgery, Fu Gu People's Hospital, Yu Lin, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xu, H., Guo, H., Tang, Z., Hao, R., Wang, S., & Jin, P. (2024). Follistatin‐like 1 protects against doxorubicin‐induced cardiotoxicity by preventing mitochondrial dysfunction through the SIRT6/Nrf2 signaling pathway. Cell Biology International, 48(6), 795-807. https://doi.org/10.1002/cbin.12147

Vancouver

Xu H, Guo H, Tang Z, Hao R, Wang S, Jin P. Follistatin‐like 1 protects against doxorubicin‐induced cardiotoxicity by preventing mitochondrial dysfunction through the SIRT6/Nrf2 signaling pathway. Cell Biology International. 2024;48(6):795-807. doi:10.1002/cbin.12147

BibTeX
@article{Xu2024,
  author = {Xu, Haijun and Guo, Hong and Tang, Zhigang and Hao, Ruijun and Wang, Shaowei and Jin, Ping},
  title = {Follistatin‐like 1 protects against doxorubicin‐induced cardiotoxicity by preventing mitochondrial dysfunction through the SIRT6/Nrf2 signaling pathway},
  journal = {Cell Biology International},
  year = {2024},
  volume = {48},
  number = {6},
  pages = {795--807},
  doi = {10.1002/cbin.12147}
}
Kostenlos starten →